Cancer Trials Ireland
- Country
- 🇮🇪Ireland
- Ownership
- Private
- Established
- 1996-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.cancertrials.ie
Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study)
- First Posted Date
- 2016-03-11
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 26
- Registration Number
- NCT02705859
- Locations
- 🇮🇪
Cancer Trials Ireland Investigative Site, Galway, Ireland
Radium-223 in Combination With Enzalutamide
- First Posted Date
- 2014-08-26
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 45
- Registration Number
- NCT02225704
- Locations
- 🇮🇪
Cork University Hospital, Cork, Ireland
🇮🇪Mater Misericordiae University Hospital, Dublin 7, Ireland
🇮🇪Mater Private Hospital, Dublin 7, Ireland
Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2014-08-18
- Last Posted Date
- 2020-07-17
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 42
- Registration Number
- NCT02219178
- Locations
- 🇮🇪
University Hospital Waterford, Waterford, Co Waterford, Ireland
🇮🇪Cork University Hospital, Cork, Ireland
🇮🇪Beaumont Hospital, Dublin, Ireland
A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Response in Advanced or Metastatic Malignant Melanoma
- Conditions
- Advanced MelanomaMetastatic Melanoma
- First Posted Date
- 2014-06-27
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 16
- Registration Number
- NCT02177110
- Locations
- 🇮🇪
Cork University Hospital, Cork, Ireland
🇮🇪Beaumont Hosptial, Dublin, Ireland
🇮🇪Mater Misericordiae University Hospital and Mater Private Hospital, Dublin, Ireland
Neo-adjuvant Abiraterone Prostate Study
- Conditions
- High Risk Localised Prostate Carcinoma
- Interventions
- First Posted Date
- 2014-06-10
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 45
- Registration Number
- NCT02160353
- Locations
- 🇮🇪
Cork University Hospital, Cork, Ireland
🇮🇪St Luke's Hospital, Dublin, Ireland
🇮🇪University Hospital Galway, Galway, Ireland
Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer
- Conditions
- Locally Advanced Rectal Cancer
- First Posted Date
- 2014-05-30
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 94
- Registration Number
- NCT02151019
- Locations
- 🇮🇪
St Luke's Radiation Oncology Network at Beaumont Hospital, Dublin, Ireland
🇮🇪St Luke's Centre for Radiation Oncology at St James Hospital, Dublin, Ireland
🇮🇪St Luke's Centre for Radiation Oncology at St Lukes Hospital, Dublin, Ireland
Plasma Biomarkers C-RAC, ICORG 12-27, V1
- Conditions
- Colorectal Cancer
- First Posted Date
- 2014-01-31
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 109
- Registration Number
- NCT02050737
- Locations
- 🇮🇪
Beacon Hospital, Bracken Rd, Sandyford Industrial Estate, Dublin 18, Ireland
🇮🇪Our Lady of Lourdes Hospital Drogheda, Drogheda, Louth, Ireland
🇮🇪Bon Secours Hosptial, Cork, Ireland
TAILORx Tissue Bank
- Conditions
- Breast Cancer
- First Posted Date
- 2014-01-31
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 600
- Registration Number
- NCT02050750
- Locations
- 🇮🇪
Bons Secours Hospital, Cork, Ireland
🇮🇪Cork University Hospital, Cork, Ireland
🇮🇪Letterkenny General Hospital, Donegal, Ireland
ABC Survey - do we Meet the Needs of Patients With Advanced Breast Cancer?
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2014-01-31
- Last Posted Date
- 2015-03-30
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 500
- Registration Number
- NCT02051010
- Locations
- 🇮🇪
Bon Secours Hospital, Cork, Ireland
🇮🇪Cork University Hospital, Cork, Ireland
🇮🇪South Infirmary - Victoria University Hospital, Cork, Ireland
Plasma Biomarkers P-DAC, V1
- Conditions
- Pancreatic Ductal Adenocarcinoma
- First Posted Date
- 2014-01-31
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 169
- Registration Number
- NCT02050997
- Locations
- 🇮🇪
Beacon Hospital, Dublin, Dublin 18, Ireland
🇮🇪Our Lady of Lourdes Hospital Drogheda, Drogheda, Louth, Ireland
🇮🇪Bon Secours, Cork, Ireland